Walleye Capital
CLSD

Walleye Capital’s Clearside Biomedical CLSD Stock Holding History

Walleye Capital’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,918
Closed -$285K – 2326
2021
Q4 		$285K Buy
+6,918
New +$448K 0.01% 1277
2021
Q3 		– Sell
-1,200
Closed -$88 – 1616
2021
Q2 		$88 Buy
+1,200
New +$55.8K ﹤0.01% 1180

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's CLSD Position: Q1 2022 in Review

Walleye Capital sold out of Clearside Biomedical (CLSD) in Q1 2022, closing a stake of 6,918 shares — an estimated $285K sold.

Walleye Capital first reported a position in CLSD in Q2 2021 and held it in 2 quarters. The position peaked at $285K in Q4 2021. 60 funds tracked by Wall St. Rank hold CLSD as of Q1 2022.

  • Walleye Capital reported no remaining Clearside Biomedical position as of Q1 2022 after selling out during the quarter.
  • Walleye Capital sold 6,918 Clearside Biomedical shares in Q1 2022, an estimated $285K.
  • Walleye Capital first reported a position in Clearside Biomedical in Q2 2021 and held it in 2 quarters.
  • Walleye Capital's Clearside Biomedical position peaked at $285K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Clearside Biomedical as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.